Intravitreal VEGF and bFGF produce florid retinal neovascularization and hemorrhage in the rabbit

Purpose. Vascular endothelial growth factor (VEGF) causes widespread retinal vascular dilation, produces breakdown of the blood-retinal barrier, and is implicated in ocular neovascularization (NV). Basic fibroblast growth factor (bFGF) also has been implicated in the production of ocular NV. This study was performed to investigate the ability of simultaneous sustained intravitreal release of both VEGF and bFGF to induce robust retinal NV in the rabbit. Methods. Intravitreal implantation of sustained-release Hydron polymeric pellets containing both 20 µg of VEGF and 20 µg of bFGF was performed on adult male Dutch belted rabbits. In other animals either 20 µg or 50 µg bFGF-containing pellets was implanted intravitreally; also, either 20 µg VEGF or 50 µg VEGF-containing pellets was implanted. Control rabbits received either blank polymeric pellets or a pellet containing 30 µg bovine serum albumin. Eyes were examined by indirect ophthalmoscopy after surgery at 24 hrs, 48 hrs, 4 days, 7 days, 14 days, 21 days, and 28 days. Findings were documented by color fundus photography and fluorescein angiography (FA). Eyes were enucleated and prepared for histologic analysis at 28 days following intravitreal implantation of the VEGF/bFGF-containing pellets. Results. In all eyes implanted with VEGF/bFGF pellets, dilation and tortuosity of existing blood vessels were observed within 48 hrs after pellet implantation. The progression of retinal vascular changes was rapid and occurred over the entire optic disk and medullary rays between 4 and 7 days. Hemorrhage occurred as early as 14 days after VEGF/bFGF pellet implantation. In eyes with massive hemorrhage, total traction retinal detachment developed after the second week. The presence of abnormal tissues at the vitreo-retinal interface within 28 days was demonstrated by light microscopy while FA showed profuse leakage of dye from anomalous vessels within the first week. Neither bFGF-exposed eyes nor control eyes showed any vascular changes. Eyes that received only VEGF-containing pellets exhibited tortuosity of existing vessels, but neither hemorrhaging nor retinal detachment occurred. Conclusions. These results demonstrate that retinal vascular changes leading to hemorrhaging is produced rapidly in the rabbit by simultaneous intravitreal release of both VEGF and bFGF. Understanding how these growth factors induce retinal NV may suggest novel therapeutic treatment strategies.

[1]  J. Folkman,et al.  Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic Retinopathy , 1995 .

[2]  S. Bressler,et al.  Age-related macular degeneration and risk factors for the development of choroidal neovascularization in the fellow eye. , 1998, Current opinion in ophthalmology.

[3]  Lois E. H. Smith,et al.  Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[4]  E S Gragoudas,et al.  Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. , 1996, Ophthalmology.

[5]  D. Hinton,et al.  Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. , 1996, Investigative ophthalmology & visual science.

[6]  S. Seregard,et al.  Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. , 1996, Investigative ophthalmology & visual science.

[7]  Zhongping Chen,et al.  Optical Doppler Tomography: Imaging in vivo Blood Flow Dynamics Following Pharmacological Intervention and Photodynamic Therapy , 1998, Photochemistry and photobiology.

[8]  P. Campochiaro,et al.  Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates. , 1998, Experimental eye research.

[9]  J. Hollyfield,et al.  Basic fibroblast growth factor (bFGF) immunolocalization in the rodent outer retina demonstrated with an anti-rodent bFGF antibody , 1992, Brain Research.

[10]  E. Keshet,et al.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.

[11]  A. Patz Clinical and experimental studies on retinal neovascularization. XXXIX Edward Jackson Memorial Lecture. , 1982, American journal of ophthalmology.

[12]  E. Keshet,et al.  Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[13]  E. Stefánsson,et al.  Retinal vasoconstriction after laser treatment for diabetic macular edema. , 1993, American journal of ophthalmology.

[14]  A. Milam,et al.  A gradient of basic fibroblast growth factor in rod photoreceptors in the normal human retina , 1997, Visual Neuroscience.

[15]  G. Brown,et al.  Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. , 1990, Archives of ophthalmology.

[16]  W. Tasman,et al.  Cryotherapy for active retinopathy of prematurity. , 1986, Ophthalmology.

[17]  Georg Breier,et al.  Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo , 1992, Nature.

[18]  E. Kohner,et al.  Levels of vascular endothelial growth factor are elevated in the vitreous of patients with subretinal neovascularisation. , 1996, The British journal of ophthalmology.

[19]  M. Lavail,et al.  Basic fibroblast growth factor and local injury protect photoreceptors from light damage in the rat , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[20]  W. Benedict,et al.  Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. , 1999, Science.

[21]  Einar Stefánsson,et al.  Retinal vessel dilatation and elongation precedes diabetic macular oedema , 1997, The British journal of ophthalmology.

[22]  George A. Williams,et al.  Anterior hyaloidal fibrovascular proliferation after diabetic vitrectomy. , 1987, American journal of ophthalmology.

[23]  Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Branch Vein Occlusion Study Group. , 1986, Archives of ophthalmology.

[24]  G. Chader,et al.  Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[25]  D. Hatchell,et al.  An experimental model of preretinal neovascularization in the rabbit. , 1991, Investigative ophthalmology & visual science.

[26]  L. Aiello,et al.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. , 1994, The New England journal of medicine.

[27]  P. D'Amore,et al.  Mechanisms of retinal and choroidal neovascularization. , 1994, Investigative ophthalmology & visual science.

[28]  Z. Nie,et al.  Retinal degeneration in transgenic mice with photoreceptor-specific expression of a dominant-negative fibroblast growth factor receptor , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[29]  C. Distler,et al.  Müller cells in vascular and avascular retinae: A survey of seven mammals , 1992, The Journal of comparative neurology.

[30]  R Hiller,et al.  Blindness caused by diabetic retinopathy. , 1974, American journal of ophthalmology.

[31]  R. Frank,et al.  On the pathogenesis of diabetic retinopathy. , 1984, Ophthalmology.

[32]  D. Eliott,et al.  Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes. , 1996, American journal of ophthalmology.

[33]  P. Campochiaro,et al.  Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal neovascularization. , 1998, The American journal of pathology.

[34]  J. Tombran-Tink,et al.  PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. , 1991, Experimental eye research.

[35]  Lois E. H. Smith,et al.  Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[36]  L. Aiello,et al.  Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[37]  R. Dacheux,et al.  Antigenic changes of rabbit retinal Müller cells in culture. , 1998, Investigative ophthalmology & visual science.

[38]  R. Engerman,et al.  Pathogenesis of Diabetic Retinopathy , 1989, Diabetes.